a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.
Ticker / NAME | Correlation To BBIO | 1D Price Change % | ||
---|---|---|---|---|
BBIO | 100% | +2.22% | ||
ARGX - BBIO | 46% Loosely correlated | +3.01% | ||
BPMC - BBIO | 46% Loosely correlated | +0.22% | ||
AXON - BBIO | 44% Loosely correlated | -0.06% | ||
ARRY - BBIO | 43% Loosely correlated | +4.43% | ||
PMN - BBIO | 43% Loosely correlated | +0.73% | ||
More |